Sionna Therapeutics, Inc.
SION · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $1,103,110 | $1,103,110 | $1,103,110 |
| - Cash | $37,788 | $38,521 | $54,837 |
| + Debt | $9,749 | $10,477 | $0 |
| Enterprise Value | $1,075,071 | $1,075,066 | $1,048,273 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | -$668 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$69,888 | -$49,750 | -$41,250 |
| % Margin | – | – | – |
| Net Income | -$61,688 | -$47,263 | -$40,240 |
| % Margin | – | – | – |
| EPS Diluted | -1.4 | -1.071 | -0.912 |
| % Growth | -30.7% | -17.4% | – |
| Operating Cash Flow | -$52,787 | -$43,699 | -$36,068 |
| Capital Expenditures | -$27 | -$1,116 | -$1,874 |
| Free Cash Flow | -$52,814 | -$44,815 | -$37,942 |